A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma

RECRUITING

Stony Brook University Hospital, Stony Brook

RECRUITING

Hospital Universitario Virgen de las Nieves, Granada

RECRUITING

Thomas Jefferson University Hospital, Philadelphia

RECRUITING

Johns Hopkins Hospital, Baltimore

RECRUITING

Universitaru Hospital La Princesa, Madrid

RECRUITING

Hospital General Universitario Morales Meseguer, Murcia

RECRUITING

Hospital Clinico Universitario Virgen De La Arrixaca, El Palmar

RECRUITING

Hospital de Cabuenes, Gijón

RECRUITING

University of Washington, Seattle

RECRUITING

Dana-Farber Cancer Institute, Boston

RECRUITING

Hospital Universitari Mutua Terrassa, Terrassa

RECRUITING

Hospital Sant Pau, Barcelona